横管导管中枢替换后的左心室外流通道阻塞:一种具有多面性方法的病例报告
Berenice Caneiro-Queija1,2, Claudio E Guerreiro1,2, Julio Echarte-Morales1,2
1Department of Cardiology, Álvaro Cunqueiro University Hospital, Vigo, Spain.
Frontiers in cardiovascular medicine
|September 5, 2024
概括
本病例报告详细介绍了经过透气管 mitra 门更换后管理左心室外流通道阻塞 (LVOTO) 的方法. 酒精隔膜切除和医疗治疗的联合策略成功地解决了阻塞.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 严重的甲状腺环状化会导致复杂的膜病变.
- 过导管 mitra 置换 (TMVR) 是一种新兴的治疗方法,用于严重的 mitra 疾病.
- 左心室外流管阻塞 (LVOTO) 是TMVR后的潜在并发症.
研究的目的:
- 在TMVR之后报告一个显著的LVOTO病例.
- 讨论管理后TMVR的挑战LVOTO.
- 为了突出酒精隔膜切除对于耐火LVOTO的成功使用.
主要方法:
- 一名患有严重的额头环状化症的患者接受了TMVR.
- 尽管预测风险低,但患者患上了严重的LVOTO.
- 酒精隔膜切除是在医疗和干预策略的结合后进行的.
主要成果:
- 患者经历了临床上显著的LVOTO耐医疗管理的耐火性.
- 酒精隔膜切除,结合医疗治疗,成功地解决了LVOTO.
- 患者的病情在干预后得到改善.
结论:
- 即使有有利的预测风险,LVOTO也可能在TMVR后发生.
- 酒精隔膜切除是TMVR后耐火性LVOTO的可行的治疗选择.
- 综合策略可能有效地管理这种具有挑战性的并发症.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...


